Europeiska investeringsbanken stöttar svenskt biotechbolag mot börsen

För första gången ger Europeiska investeringsbanken (EIB) ett riktat rådgivningsstöd till ett tillväxtbolag inför en möjlig börsnotering. Valet har fallit på de...

Raise-In AB

“BioArctic is Leqembi, but also much more”

What once began as a small Swedish biotech company has grown into a fully fledged pharmaceutical company with global reach. At the helm is Gunilla Osswald, who ...

Astra Zeneca faces potential multimillion-dollar fines in China

Astra Zeneca could be forced to pay up up to $8 million in fines for allegedly unpaid import duties in China, as the company seeks to rebuild trust following ea...

ISO 13485 Standard Internal Auditing Course

Do you work with medical devices and quality management? Strengthen your expertise with our ISO 13485 Standard Internal Auditing Training — designed to give you...

Merck KGaA acquires American company in €3.0 billion deal

Germany’s Merck is completing the acquisition of Springwork Therapeutics for 3 billion euros.

Positiva resultat för Astra Zenecas KOL-kandidat

Nya fas III-data ger stöd för Astra Zenecas KOL-kandidat. Tozorakimab minskar risken för försämringsperioder hos patienter.

Higher throughput in less time

Do you want to automate your quality processes, shorten inspection times and increase your throughput? Gain inspiration from the experience of the medical techn...

Paul Chaplin steps down as CEO of Bavarian Nordic

Danish vaccine company Bavarian Nordic’s CEO, Paul Chaplin, is stepping down from his position for personal reasons.

SupraCube - In life Science

Superconductors must be permanently kept below their transition temperature for levitation. Because of the integrated cooler, applications with superconductors ...

ZEISS continues to drive digital era forward in ophthalmology

2 million digitally planned cataract cases in the U.S. alone.

Pfizer/Valneva ansöker om godkännande för vaccin mot borrelia

Pfizer och Valneva kommer att ansöka om godkännande för sitt borreliavaccin efter fas III‑resultat som beskrivs som ”kliniskt meningsfulla”.

Uppgifter: Trump planerar att sparka FDA-chefen

FDA:s högsta chef kan bli näst på tur att bli av med jobbet. Vita huset har godkänt en plan att avskeda Marty Makary, enligt källor med insyn i ärendet.

A healthy society requires more than a new pill

Sarah Lidé on how medicines are essential – but a sustainable approach to healthy societies also depends on prevention and behavioural change

The Versatile Solution for Quality Management and Data Analysis

Join our ZEISS PiWeb webinar on March 26.

In-Depth Insights into the Most Useful ZEISS Metrology Expert Tips

Free webinar June 24th, 2025, 9:00-9:45 AM and 5:00-5:45 PM.

Cell-free cartilage from Lund could pave the way for new bone transplants

Researchers at Lund University have developed a new method for repairing large bone defects, based on laboratory-engineered, cell-free cartilage grafts. The tec...

Lovande tidiga data för Lillys genredigerande blodfettsänkare

En genterapikandidat från Eli Lilly sänkte nivån av kolesterol med upp till 62 procent i en fas I-studie.

Radiofarmakabolaget Aktis tar in miljardbelopp

Amerikanska biotechbolaget Aktis Oncology, som utvecklar radiofarmaka, tar in 175 miljoner amerikanska dollar, motsvarande cirka 1,8 miljarder svenska kronor, g...

Novo Nordisk strengthens board after turbulent year

Changes to Novo Nordisk’s board continue. Following last year’s sweeping restructuring, the Danish obesity drugmaker is now nominating two new directors with ex...

Efter förseningen – nu lämnar Xspray in uppdaterad FDA-ansökan

Forskningsbolaget Xspray Pharma har nu lämnat in en uppdaterad FDA-ansökan om godkännande för leukemibehandlingen Dasynoc.

Precision, balance and clinical experience

Phase II is often the most crucial phase of clinical development. This is where the study design is validated in practice, effect must be demonstrated, and wher...

How Microscopy Can Help Families Grow

Advanced microscopy solutions can help bypass challenges and natural barriers of conception.

We are expanding our English-language coverage

Over a period of four weeks, one of Life Science Sweden's regular daily newsletters is being published entirely in English. The aim is to meet increasing demand...